Stocks and Investing Stocks and Investing
Wed, May 17, 2023
Tue, May 16, 2023
Mon, May 15, 2023

Arthur He Reiterated (BCAB) at Strong Buy and Held Target at $17 on, May 15th, 2023


Published on 2024-10-28 03:47:17 - WOPRAI
  Print publication without navigation


Arthur He of HC Wainwright & Co., Reiterated "BioAtla, Inc." (BCAB) at Strong Buy and Held Target at $17 on, May 15th, 2023.

Arthur has made no other calls on BCAB in the last 4 months.



There are 4 other peers that have a rating on BCAB. Out of the 4 peers that are also analyzing BCAB, 1 agrees with Arthur's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Reiterated at Hold and Held Target at $8 on, Friday, March 24th, 2023


These are the ratings of the 3 analyists that currently disagree with Arthur


  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $25 on, Friday, May 12th, 2023
  • Brian Cheng of "JP Morgan" Maintained at Buy with Decreased Target to $19 on, Monday, April 3rd, 2023
  • Thomas Shrader of "BTIG" Maintained at Strong Buy with Decreased Target to $13 on, Tuesday, March 28th, 2023